Heparin Sodium Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Heparin Sodium Injection (injection) from B. Braun Medical Inc. with status Current. The shortage was first posted on 11/14/2017. Reported reason: Requirements related to complying with good manufacturing practices
Shortage Details
- Status
- Current
- Company
- B. Braun Medical Inc.
- Package NDC
- 0264-9872-00
- Dosage Form
- Injection
- Presentation
- Heparin Sodium 2,000 Units in Sodium Chloride 0.9% in Plastic Container, Injection, 200 [USP'U]/100 mL (NDC 0264-9872-00)
- Initial Posting
- 11/14/2017
- Revised Date
Reason
Requirements related to complying with good manufacturing practices